JX 929Alternative Names: JX-929; vvDD-CDSR
Latest Information Update: 28 Apr 2016
At a glance
- Originator Jennerex
- Developer University of Pittsburgh
- Class Antineoplastics; Oncolytic viruses
- Mechanism of Action Cytosine deaminase modulators; Epidermal growth factor receptor modulators; Somatostatin receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours